Patients with Parkinson disease were shown to be at greater risk of suicide than matched participants in the general population, according to study findings published last week.
Patients with Parkinson disease (PD) were shown to be at greater risk of suicide than control matched participants in the general population, according to study findings published last week in JAMA Psychiatry.
In prior studies, risk of mental health disorders such as depression and anxiety has been noted as greater among PD populations. Moreover, the adverse implications of the coronavirus disease 2019 pandemic have brought about a rise in feelings of loneliness amid social distancing regulations, which was associated with greater patient-reported PD severity and lower quality of life.
In the present study, researchers acknowledge the common nature of comorbidities with mental disorders among patients with PD (PwP), but they note that it is unclear whether this stark risk may be associated with an increased risk of suicide.
“PD causes progressive physical disability, which is an important suicide risk factor in younger and middle-aged populations; whether PD is associated with elevated suicide risk is understudied,” highlighted the researchers.
Utilizing a large representative PD cohort within Taiwan’s National Health Insurance system, researchers compared the risk of suicide in PwP (n = 35,891; women = 17,482 [48.7%]; mean [SD] age = 72.5 [10.1] years) and control-matched participants of the general population (n = 143,577; women = 69,928 [48.7%]; mean [SD] age = 72.5 [10.1] years), with several potential risk factors additionally examined:
PwP diagnosed between January 2005 and December 2014 were followed up until December 2016, with Cox proportional models and HRs used to estimate the association between PD and the risk of suicide over the follow-up period.
Across the time span of the study, a total of 151 PwP and 300 control participants were found to have died by suicide. Researchers found that the risk of suicide in PwP was more than 2-fold the risk in control participants (HR, 2.1; 95% CI, 1.7-2.5) after adjusting for markers of socioeconomic position, medical comorbidities, and dementia.
The association between PD and suicide risk remained after controlling for mental disorders, with PwP shown to be at a nearly 2 times greater risk than control participants (HR, 1.9; 95% CI, 1.6-2.3). Notably, those who died by suicide in the PD cohort were slightly younger than control participants who died by suicide (patients with PD: mean [SD] age = 74.0 [10.4] years; control participants: mean [SD] age = 76.0 [10.2] years; P = .05), with PwP also found to be more likely to live in urban areas and have mental disorders:
“Integrating mental health care into primary care and PD specialty care, along with socioenvironmental interventions, may help decrease the risk of suicide in patients with PD,” concluded the study authors.
Reference
Chen YY, Yu S, Hu YH, et al. Risk of suicide among patients with Parkinson disease. JAMA Psychiatry. Published online December 16, 2020. doi:10.1001/jamapsychiatry.2020.4001
If you are thinking about suicide, please call the National Suicide Prevention Lifeline at 800-273-TALK (8255).
Major Study Expands in Hopes to Cure Parkinson Disease
April 19th 2022April is Parkinson’s Disease Awareness month, and on this episode of Managed Care Cast, we take a look at the Parkinson's Progression Markers Initiative (PPMI), a study from the Michael J. Fox Foundation for Parkinson's Research (MJFF). The multicenter, international study aims to end Parkinson disease, which is expected to double worldwide by 2040, to more than 14 million people.
Listen
Certain Patient Groups Continue to Be Underrepresented in PD Studies in the Netherlands
February 4th 2023With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.
Read More
An Inside Look at Innovations by MJFF to Assist the Parkinson Community Amid the COVID-19 Pandemic
May 26th 2020On this episode of Managed Care Cast, we speak with Rachel Dolhun, MD, vice president of Medical Communications at The Michael J. Fox Foundation for Parkinson Research, about recent innovations by The Michael J. Fox Foundation to assist patients and families of patients with Parkinson disease in adjusting to this new normal.
Listen
Motor Symptoms May Occur 3 Years Before Parkinson Disease Diagnosis, Study Says
January 20th 2023Trouble with balance and holding objects above one's head were just a few of the problems reported by patients 3 years before they received a formal Parkinson disease diagnosis, according to a recent study.
Read More